Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.64 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 3/20 | 0.57 |
| ▸ | ATM | Q13315 | 1/20 | 0.54 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.53 |
| ▸ | RAD52 | P43351 | 1/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
| ▸ | DGKA | P23743 | 1/20 | 0.52 |
| ▸ | ACHE | P22303 | 6/20 | 0.52 |
| ▸ | FAAH | O00519 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1837332 | 1.00 | NAAA (0.64) | NAAAEPHX1ALDH1A1TSHRATM | |
| SCHEMBL1837671 | 1.00 | NAAA (0.64) | NAAAEPHX1ALDH1A1TSHRATM | |
| SCHEMBL1832878 | 1.00 | NAAA (0.64) | NAAAEPHX1ALDH1A1TSHRATM | |
| SCHEMBL1839292 | 1.00 | NAAA (0.64) | NAAAEPHX1ALDH1A1TSHRATM | |
| SCHEMBL1840875 | 1.00 | NAAA (0.64) | NAAAEPHX1ALDH1A1TSHRATM | |
| SCHEMBL1837204 | 1.00 | NAAA (0.64) | NAAAEPHX1ALDH1A1TSHRATM | |
| SCHEMBL1841631 | 1.00 | NAAA (0.64) | NAAAEPHX1ALDH1A1TSHRATM | |
| SCHEMBL1838117 | 1.00 | NAAA (0.64) | NAAAEPHX1ALDH1A1TSHRATM | |
| SCHEMBL1839513 | 1.00 | NAAA (0.64) | NAAAEPHX1ALDH1A1TSHRATM | |
| SCHEMBL1834437 | 1.00 | NAAA (0.64) | NAAAEPHX1ALDH1A1TSHRATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4446310-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | Asahi Kasei Kabushiki Kaisha (JP) | 2024-10-16 | — | — | EP | disclosed |
| US-11565244-B2 | Catalyst precursor | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2023-01-31 | — | — | US | disclosed |
| EP-3838892-B1 | METHOD FOR PRODUCING ISOCYANATE | ASAHI CHEMICAL IND (JP) | 2022-10-12 | — | — | EP | disclosed |
| US-20220297099-A1 | CATALYST PRECURSOR | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2022-09-22 | — | — | US | disclosed |
| US-11400440-B2 | Catalyst and precursor thereof and method of forming dialkyl carbonate | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2022-08-02 | — | — | US | disclosed |
| US-20220209301-A1 | CARBONATE SOLVENTS FOR NON-AQUEOUS ELECTROLYTES FOR METAL AND METAL-ION BATTERIES | SCE FRANCE (FR) | 2022-06-30 | — | — | US | disclosed |
| EP-3956288-A1 | CARBONATE SOLVENTS FOR NON-AQUEOUS ELECTROLYTES FOR METAL AND METAL-ION BATTERIES | SCE France (FR) | 2022-02-23 | — | — | EP | disclosed |
| CN-113795963-A | Carbonate solvents for non-aqueous electrolytes for metal and metal ion batteries | 斯塞法国公司 | 2021-12-14 | — | — | CN | disclosed |
| EP-3293173-B1 | METHOD FOR PRODUCING ISOCYANATE | ASAHI CHEMICAL IND (JP) | 2021-07-28 | — | — | EP | disclosed |
| EP-3838892-A1 | METHOD FOR PRODUCING ISOCYANATE | Asahi Kasei Kabushiki Kaisha (JP) | 2021-06-23 | — | — | EP | disclosed |
| EP-1640357-B1 | METHOD FOR PRODUCING AROMATIC CARBONATE | ASAHI KASEI CHEMICALS CORP (JP) | 2011-08-31 | — | — | EP | disclosed |
| US-20110160476-A1 | N-Substituted Carbamic Acid Ester Production Method and Isocyanate Production Method Using the N-Substituted Carbamic Acid Ester | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2011-06-30 | — | — | US | disclosed |
| US-20110133121-A1 | N-Substituted Carbamic Acid Ester Production Method, Isocyanate Production Method Using Such N-Substituted Carbamic Acid Ester, And Composition For Transfer And Storage Of N-Substituted Carbamic Acid Ester Comprising N-Substituted Carbamic Acid Ester and Aromatic Hydroxy Compound | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2011-06-09 | — | — | US | disclosed |
| EP-2322504-A1 | PROCESS FOR THE PREPARATION OF N-SUBSTITUTED CARBAMIC ACID ESTER AND PROCESS FOR THE PREPARATION OF ISOCYANATE USING THE N-SUBSTITUTED CARBAMIC ACID ESTER | Asahi Kasei Chemicals Corporation (JP) | 2011-05-18 | — | — | EP | disclosed |
| US-7652122-B2 | Method for producing an aromatic carbonate | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2010-01-26 | — | — | US | disclosed |
| US-20070055042-A1 | Method for producing an aromatic carbonate | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2007-03-08 | — | — | US | disclosed |
| EP-1640357-A1 | METHOD FOR PRODUCING AROMATIC CARBONATE | Asahi Kasei Chemicals Corporation (JP) | 2006-03-29 | — | — | EP | disclosed |
| US-5827863-A | Pyrazole derivatives as angiotensin II antagonists | J. URIACH & CIA, S.A. (ES) | 1998-10-27 | — | — | US | disclosed |
| WO-1996004273-A1 | NEW PYRAZOLE DERIVATIVES AS ANGIOTENSIN II ANTAGONIST | J. URIACH & CIA, S.A. (ES) | 1996-02-15 | — | — | WO | disclosed |
| US-3992453-A | Hydroformylation process | UNIVERSAL OIL PRODUCTS COMPANY (US) | 1976-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220297099-A1 | CATALYST PRECURSOR | OR10J3, CCNL2, SMARCC2 | NAAA 3172/4885EPHX1 4509/4885ALDH1A1 1448/4885 |
| US-20110133121-A1 | N-Substituted Carbamic Acid Ester Production Method, Isocyanate Production Method Using Such N-Substituted Carbamic Acid Ester, And Composition For Transfer And Storage Of N-Substituted Carbamic Acid Ester Comprising N-Substituted Carbamic Acid Ester and Aromatic Hydroxy Compound | CPS1, ALKBH3, RCC1 | NAAA 57/4885EPHX1 1711/4885ALDH1A1 1568/4885 |
| US-11565244-B2 | Catalyst precursor | OR10J3, CCNL2, SMARCC2 | NAAA 3172/4885EPHX1 4509/4885ALDH1A1 1448/4885 |
| US-20110160476-A1 | N-Substituted Carbamic Acid Ester Production Method and Isocyanate Production Method Using the N-Substituted Carbamic Acid Ester | ALKBH3, CPS1, APEH | NAAA 4/4885EPHX1 533/4885ALDH1A1 574/4885 |
| US-11400440-B2 | Catalyst and precursor thereof and method of forming dialkyl carbonate | OR10J3, ADH1C, DECR1 | NAAA 3372/4885EPHX1 4416/4885ALDH1A1 898/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.